Peer Comparison or Guideline-Based Feedback and Postsurgery Opioid Prescriptions: A Randomized Clinical Trial.
Journal
JAMA health forum
ISSN: 2689-0186
Titre abrégé: JAMA Health Forum
Pays: United States
ID NLM: 101769500
Informations de publication
Date de publication:
01 Mar 2024
01 Mar 2024
Historique:
medline:
18
3
2024
pubmed:
15
3
2024
entrez:
15
3
2024
Statut:
epublish
Résumé
Excess opioid prescribing after surgery can result in prolonged use and diversion. Email feedback based on social norms may reduce the number of pills prescribed. To assess the effectiveness of 2 social norm-based interventions on reducing guideline-discordant opioid prescribing after surgery. This cluster randomized clinical trial conducted at a large health care delivery system in northern California between October 2021 and October 2022 included general, obstetric/gynecologic, and orthopedic surgeons with patients aged 18 years or older discharged to home with an oral opioid prescription. In 19 hospitals, 3 surgical specialties (general, orthopedic, and obstetric/gynecologic) were randomly assigned to a control group or 1 of 2 interventions. The guidelines intervention provided email feedback to surgeons on opioid prescribing relative to institutionally endorsed guidelines; the peer comparison intervention provided email feedback on opioid prescribing relative to that of peer surgeons. Emails were sent to surgeons with at least 2 guideline-discordant prescriptions in the previous month. The control group had no intervention. The probability that a discharged patient was prescribed a quantity of opioids above the guideline for the respective procedure during the 12 intervention months. There were 38 235 patients discharged from 640 surgeons during the 12-month intervention period. Control-group surgeons prescribed above guidelines 36.8% of the time during the intervention period compared with 27.5% and 25.4% among surgeons in the peer comparison and guidelines arms, respectively. In adjusted models, the peer comparison intervention reduced guideline-discordant prescribing by 5.8 percentage points (95% CI, -10.5 to -1.1; P = .03) and the guidelines intervention reduced it by 4.7 percentage points (95% CI, -9.4 to -0.1; P = .05). Effects were driven by surgeons who performed more surgeries and had more guideline-discordant prescribing at baseline. There was no significant difference between interventions. In this cluster randomized clinical trial, email feedback based on either guidelines or peer comparison reduced opioid prescribing after surgery. Guideline-based feedback was as effective as peer comparison-based feedback. These interventions are simple, low-cost, and scalable, and may reduce downstream opioid misuse. ClinicalTrials.gov NCT05070338.
Identifiants
pubmed: 38488780
pii: 2816471
doi: 10.1001/jamahealthforum.2024.0077
pmc: PMC10943416
doi:
Substances chimiques
Analgesics, Opioid
0
Banques de données
ClinicalTrials.gov
['NCT05070338']
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e240077Références
BMJ. 2017 Oct 19;359:j4792
pubmed: 29051174
Ann Surg. 2018 Mar;267(3):468-472
pubmed: 28267689
JAMA Netw Open. 2022 Jul 1;5(7):e2221316
pubmed: 35838671
Ann Surg. 2018 Aug;268(2):271-276
pubmed: 28594744
JAMA Psychiatry. 2018 Oct 1;75(10):1003-1011
pubmed: 30073273
Health Aff (Millwood). 2022 Mar;41(3):424-433
pubmed: 35254932
Obstet Gynecol. 2017 Jul;130(1):29-35
pubmed: 28594763
JAMA Netw Open. 2021 Jan 4;4(1):e2031073
pubmed: 33410876
Gynecol Oncol. 2020 May;157(2):476-481
pubmed: 32107048
Ann Surg. 2018 Sep;268(3):457-468
pubmed: 30004924
JTCVS Open. 2021 Apr 22;8:467-474
pubmed: 36004108
N Engl J Med. 2019 Aug 15;381(7):680-682
pubmed: 31412184
JB JS Open Access. 2020 Mar 03;5(1):e0050
pubmed: 32309760
Acad Emerg Med. 2018 May;25(5):482-493
pubmed: 29498155
Syst Rev. 2020 Jun 11;9(1):139
pubmed: 32527307
JAMA Surg. 2018 Nov 1;153(11):1012-1019
pubmed: 30027289
Int J Epidemiol. 2023 Feb 8;52(1):107-118
pubmed: 35834775
Lancet Infect Dis. 2023 May;23(5):e175-e184
pubmed: 36521504
JAMA Health Forum. 2022 Sep 2;3(9):e223378
pubmed: 36218952
JAMA. 2017 May 16;317(19):2013-2015
pubmed: 28510669
N Engl J Med. 2016 Jan 14;374(2):154-63
pubmed: 26760086
BMJ Open. 2022 Sep 19;12(9):e061980
pubmed: 36123066
JAMA Surg. 2017 Jun 21;152(6):e170504
pubmed: 28403427
J Pers Soc Psychol. 2011 Mar;100(3):433-48
pubmed: 21171790
Surgery. 2022 Nov;172(5):1407-1414
pubmed: 36088172
Ann Surg Oncol. 2019 Jan;26(1):17-24
pubmed: 30238243
Clin Orthop Relat Res. 2019 Jan;477(1):104-113
pubmed: 30794233
Health Aff (Millwood). 2020 May;39(5):852-861
pubmed: 33166482
JCO Oncol Pract. 2022 Jul;18(7):e1122-e1131
pubmed: 35377734
Am J Prev Med. 2015 Sep;49(3):409-13
pubmed: 25896191
Health Aff (Millwood). 2023 Jan;42(1):140-149
pubmed: 36623221
Ann Surg. 2023 Jun 1;277(6):944-951
pubmed: 36727966
JAMA Netw Open. 2022 Jun 1;5(6):e2219701
pubmed: 35771572
Biometrics. 1999 Jun;55(2):652-9
pubmed: 11318229
Lancet. 2019 Apr 13;393(10180):1547-1557
pubmed: 30983590
JAMA Health Forum. 2022 Jul 29;3(7):e222263
pubmed: 35983579
Am J Med Qual. 2023 Jan-Feb 01;38(1):1-8
pubmed: 36579960
J Manag Care Spec Pharm. 2022 Aug;28(8):862-870
pubmed: 35876292
Ann Surg. 2017 Apr;265(4):709-714
pubmed: 27631771
Science. 2018 Aug 10;361(6402):588-590
pubmed: 30093595
Ann Surg. 2020 Feb;271(2):266-278
pubmed: 31356268